NRx Pharmaceuticals Ownership | Who Owns NRx Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

NRx Pharmaceuticals Ownership Summary


NRx Pharmaceuticals is owned by 28.79% institutional investors, 8.30% insiders, and 62.91% retail investors. B group is the largest institutional shareholder, holding 14.02% of NRXP shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 2.96% of its assets in NRx Pharmaceuticals shares.

NRXP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNRx Pharmaceuticals28.79%8.30%62.91%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
B group3.00M14.02%$6.39M
Vanguard group729.84K3.28%$1.98M
Advisorshares investments420.47K1.96%$895.60K
Commonwealth equity services397.43K1.86%$846.53K
Geode capital management310.11K1.45%$660.61K
Vanguard fiduciary trust169.58K0.79%$361.20K
Bleakley financial group117.20K0.55%$249.65K
Blackrock funding, inc. /de99.00K0.46%$210.86K
State street86.98K0.41%$185.28K
Xtx topco78.73K0.37%$167.70K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
B group3.00M4.74%$6.39M
Advisorshares investments420.47K0.16%$895.60K
One wealth management investment & advisory services37.87K0.11%$102.64K
Bleakley financial group117.20K0.00%$249.65K
Xtx topco78.73K0.00%$167.70K
Virtu financial31.79K0.00%$68.00K
Ethos financial group15.90K0.00%$33.87K
Chicago partners investment group34.48K0.00%$102.40K
Global retirement partners39.30K0.00%$106.50K
Commonwealth equity services397.43K0.00%$846.53K

Top Buyers

HolderShares% AssetsChange
B group3.00M4.74%3.00M
Vanguard group729.84K-194.89K
Vanguard fiduciary trust169.58K0.00%169.58K
Advisorshares investments420.47K0.16%92.46K
Geode capital management310.11K-91.25K

Top Sellers

HolderShares% AssetsChange
Anson funds management lp---3.04M
Marshall wace, llp---189.14K
Renaissance---128.18K
Squarepoint ops---42.20K
Headlands---39.39K

New Positions

HolderShares% AssetsChangeValue
B group3.00M4.74%3.00M$6.39M
Vanguard fiduciary trust169.58K0.00%169.58K$361.20K
Xtx topco78.73K0.00%78.73K$167.70K
Global retirement partners39.30K0.00%39.30K$106.50K
Virtu financial31.79K0.00%31.79K$68.00K

Sold Out

HolderChange
Carolina wealth advisors-50.00
Simplex trading-690.00
Group one trading-737.00
Clear street markets-1.14K
Raymond james financial-2.57K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20263719.35%6,161,67017.69%285.19%2237.50%3-66.67%
Dec 31, 202510-62.96%1,162,134-70.63%51.07%3-83.33%3-
Sep 30, 20258-65.22%961,561-66.82%51.72%5-64.29%1-66.67%
Jun 30, 2025258.70%2,994,36832.46%189.62%1550.00%4-33.33%
Mar 31, 202523-14.81%2,260,524115.57%1313.86%10-37.50%6200.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Morn Total Stk Mkt Idx Investor1.27M2.96%302.20K
Vanguard Total Stock Mkt Idx Inv1.27M2.96%302.20K
AdvisorShares Psychedelics ETF731.05K1.71%-
Vanguard US Total Market Shares ETF193.42K1.23%-
Vanguard Institutional Extnd Mkt Idx Tr313.88K0.73%22.49K
Fidelity Extended Market Index144.93K0.34%13.63K
KoAct US Brain Treatment Active41.02K0.26%41.02K
iShares Micro-Cap ETF103.59K0.24%-1.38K
Abante Quant Value FI101.47K0.24%-
BlackRock Extended Equity Market Fund K71.61K0.17%66.65K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 17, 2024Javitt Jonathan C Chairman and Chief ScientistBuy$46.80K
Aug 30, 2023Gorovitz Aaron-Buy$11.20K
Aug 30, 2023Hurvitz Chaim-Buy$20.13K
Aug 23, 2023Javitt Jonathan C Chief ScientistBuy$33.00K
Aug 22, 2023Javitt Jonathan C Chief ScientistBuy$64.40K

Insider Transactions Trends


DateBuySell
2024 Q41-
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q34-

NRXP Ownership FAQ


Who Owns NRx Pharmaceuticals?

NRx Pharmaceuticals shareholders are primarily institutional investors at 28.79%, followed by 8.30% insiders and 62.91% retail investors. The average institutional ownership in NRx Pharmaceuticals's industry, Biotech Stocks , is 35.43%, which NRx Pharmaceuticals falls below.

Who owns the most shares of NRx Pharmaceuticals?

NRx Pharmaceuticals’s largest shareholders are B group (3M shares, 14.02%), Vanguard group (729.84K shares, 3.28%), and Advisorshares investments (420.47K shares, 1.96%). Together, they hold 19.27% of NRx Pharmaceuticals’s total shares outstanding.

Does Blackrock own NRx Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of NRx Pharmaceuticals.

Who is NRx Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

B group is NRx Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.74% of its assets in 3M NRx Pharmaceuticals shares, valued at 6.39M$.

Who is the top mutual fund holder of NRx Pharmaceuticals shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of NRx Pharmaceuticals shares, with 2.96% of its total shares outstanding invested in 1.27M NRx Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools